{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-052454","form_type":"8-K","ticker":"LQDA","cik":"0001819576","company_name":"Liquidia Corp","filed_at":"2025-05-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.877999+00:00","generated_at":"2026-05-20T15:06:31.029853+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"FDA approves Liquidia's YUTREPIA for PAH and PH-ILD, enabling commercial launch","bullets":["FDA approved YUTREPIA (treprostinil) inhalation powder for PAH and PH-ILD to improve exercise ability.","Exclusivity for United Therapeutics' Tyvaso DPI expired May 23, 2025, clearing path for YUTREPIA final approval.","YUTREPIA uses proprietary PRINT technology for deep-lung delivery; pivotal INSPIRE study showed tolerability.","Liquidia intends to begin commercialization immediately; ongoing litigation may delay or prevent successful commercialization.","Company will host a webcast May 27, 2025 at 8:30 a.m. ET to discuss commercial launch preparations."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-052454","json":"https://secwatch.observer/filing/0001104659-25-052454.json","markdown":"https://secwatch.observer/filing/0001104659-25-052454.md","text":"https://secwatch.observer/filing/0001104659-25-052454.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1819576/000110465925052454/0001104659-25-052454-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1819576/000110465925052454/tm2516078d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T15:06:31.029853+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}